港股异动 | 精优药业(00858)盘中拉升逾13% 拟配发合共1.6亿股净筹款项用于潜在新业务发展

智通财经08-15

智通财经APP获悉，精优药业(00858)盘中拉升逾13%%，截至发稿，涨13.56%，报0.134港元，成交额232.3万港元。消息面上，精优药业发布公告，于2025年8月14日(交易时段后)，公司与认购方I订立认购协议I，据此，认购方I已有条件同意认购，而公司已有条件同意按认购价(I总金额为291万港元，相等于每股认购股份I0.097港元)配发及发行合共3000万股认购股份I。根据认购协议I...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2559995018?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-15 10:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2559995018","market":"hk","top_or_hot":-1,"title":"港股异动 | 精优药业(00858)盘中拉升逾13% 拟配发合共1.6亿股 净筹款项用于潜在新业务发展","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，精优药业(00858)盘中拉升逾13%%，截至发稿，涨13.56%，报0.134港元，成交额232.3万港元。消息面上，精优药业发布公告，于2025年8月14日(交易时段后)，公司与认购方I订立认购协议I，据此，认购方I已有条件同意认购，而公司已有条件同意按认购价(I总金额为291万港元，相等于每股认购股份I0.097港元)配发及发行合共3000万股认购股份I。根据认购协议I...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1329945.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 精优药业(00858)盘中拉升逾13% 拟配发合共1.6亿股 净筹款项用于潜在新业务发展</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 精优药业(00858)盘中拉升逾13% 拟配发合共1.6亿股 净筹款项用于潜在新业务发展\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-15 10:02 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1329945.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，精优药业(00858)盘中拉升逾13%%，截至发稿，涨13.56%，报0.134港元，成交额232.3万港元。消息面上，精优药业发布公告，于2025年8月14日(交易时段后)，公司与认购方I订立认购协议I，据此，认购方I已有条件同意认购，而公司已有条件同意按认购价(I总金额为291万港元，相等于每股认购股份I0.097港元)配发及发行合共3000万股认购股份I。根据认购协议I...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1329945.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00858","symbol_name":"精优药业","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1329945.html","article_id":"2559995018","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2559995018","pubTimestamp":1755223324,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，精优药业盘中拉升逾13%%，截至发稿，涨13.56%，报0.134港元，成交额232.3万港元。消息面上，精优药业发布公告，于2025年8月14日，公司与认购方I订立认购协议I，据此，认购方I已有条件同意认购，而公司已有条件同意按认购价配发及发行合共3000万股认购股份I。认购事项III须待条件III达成后方可作实。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"00858":"精优药业","BK1191":"制药"},"translate_title":"Changes in Hong Kong stocks | Jingyou Pharmaceutical (00858) rose more than 13% during the session and plans to allocate a total of 160 million shares in net fundraising for potential new business development","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00858":1},"content_text":"智通财经APP获悉，精优药业(00858)盘中拉升逾13%%，截至发稿，涨13.56%，报0.134港元，成交额232.3万港元。消息面上，精优药业发布公告，于2025年8月14日(交易时段后)，公司与认购方I订立认购协议I，据此，认购方I已有条件同意认购，而公司已有条件同意按认购价(I总金额为291万港元，相等于每股认购股份I0.097港元)配发及发行合共3000万股认购股份I。根据认购协议I进行之认购事项I须待条件I达成后方可作实。于2025年8月14日(交易时段后)，公司与认购方II订立认购协议II，据此，认购方II已有条件同意认购，而公司已有条件同意按认购价II(总金额为194万港元，相等于每股认购股份II0.097港元)配发及发行合共2000万股认购股份II。认购事项II须待条件II达成后方可作实。于2025年8月14日(交易时段后)，公司与认购方III订立认购协议III，据此，认购方III已有条件同意认购，而公司已有条件同意按认购价III(总金额为1067万港元，相等于每股认购股份III0.097港元)配发及发行合共1.1亿股认购股份III。认购事项III须待条件III达成后方可作实。公司拟将认购事项的所得款项净额用于集团在中国的保健产品、设备和技术贸易、制造、销售和分销业务的潜在新业务发展，并将与保健领域相关的业务机会扩展至海外市场，同时集团将继续通过分配其现有内部产生的现金资源来维持和发展其现有的医药业务。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2559995018","isCrawlerRequest":true}

港股异动 | 精优药业(00858)盘中拉升逾13% 拟配发合共1.6亿股 净筹款项用于潜在新业务发展

精彩评论

港股异动 | 精优药业(00858)盘中拉升逾13% 拟配发合共1.6亿股净筹款项用于潜在新业务发展